Radiosurgery Can Help Patients with Severe Obsessive-Compulsive Disorder
7-Jan-2011 8:00 AM EST
May Be Effective New Option for Those Who Don't Respond to Medications
Newswise — For patients with extremely severe obsessive-compulsive disorder (OCD), a procedure called radiosurgery may bring improvement when other treatments have failed, according to a study in the January issue of Neurosurgery, official journal of the Congress of Neurological Surgeons. The journal is published by Lippincott Williams & Wilkins, a part of Wolters Kluwer Health.
Dr. Douglas Kondziolka and colleagues of University of Pittsburgh report promising results of radiosurgery in three patients with very severe, "medically refractory" OCD. Although further research is needed, radiosurgery could provide a new treatment alternative for the most extreme and difficult cases of OCD. Radiation Treatment Brings Improvement Where Medications Have FailedThe patients were two women and one man with extremely severe OCD—on a standard OCD severity scale, two of the patients scored 39 out of 40. Despite taking multiple medications, all patients continued to have severe and disabling OCD symptoms. For example, one woman spent hours washing every day and had not left her house for a year.
After exhausting all other treatment options, the three patients underwent radiosurgery. In this procedure, a piece of equipment called a "gamma knife" is used to deliver an intense beam of radiation targeted precisely to the area of the brain (the anterior cingulate cortex) responsible for OCD symptoms. Radiosurgery was originally developed as a way of using radiation to destroy brain tumors, as an alternative to surgery.
The experimental procedure was tried only after careful evaluation. In addition to meeting criteria for extreme OCD, the patients had to request radiosurgery, and the procedure had to be recommended by at least two psychiatrists. All radiosurgery procedures were performed without complications; the patients were followed for up to 4½ years.
"All patients noted significant functional improvements and reduction in OCD behavior," Dr. Kondizolka and co-authors write. For example, the patient obsessed with washing reduced her bathing routine from four to two hours per day and was able to leave the house for daily activities.
The other two patients also improved; one had a 90 percent reduction in her OCD severity score. The improvements occurred gradually, typically peaking between two and four months. All patients had to continue taking medications—one patient's OCD symptoms began to worsen again when he stopped taking medications.
Although most patients with OCD improve with drug treatment, some continue to have severe and disabling symptoms even with extensive medications. Some patients have benefited from a surgical procedure (anterior cingulotomy) performed on the involved area of the brain. More recently, deep brain stimulation (DBS)—using electrical stimulation applied to disrupt abnormal brain activity—has been approved for use in severe OCD.
Although preliminary, the new results suggest that radiosurgery could offer a valuable new option for those most severe cases of OCD. Radiosurgery has some potential disadvantages compared to DBS: the procedure is irreversible and doesn't allow adjustment of stimulation patterns, which is possible with DBS. On the other hand, radiosurgery doesn't require implanted electrodes and generators and avoids the equipment-related complications that are possible with DBS.
Much more research will be needed before radiosurgery can be widely recommended for patients with severe OCD. Dr. Kondziolka and colleagues call for studies comparing radiosurgery with DBS, including the benefits, risks, and costs of the two treatments.
About NeurosurgeryNeurosurgery, the Official Journal of the Congress of Neurological Surgeons, is your most complete window to the contemporary field of neurosurgery. Members of the Congress and non-member subscribers receive 3,000 pages per year packed with the very latest science, technology, and medicine, not to mention full-text online access to the world's most complete, up-to-the-minute neurosurgery resource. For professionals aware of the rapid pace of developments in the field, Neurosurgery is nothing short of indispensable. Visit the journal online at www.neurosurgery-online.com/.
About Lippincott Williams & Wilkins Lippincott Williams & Wilkins (LWW) is a leading international publisher for healthcare professionals and students with nearly 300 periodicals and 1,500 books in more than 100 disciplines publishing under the LWW brand, as well as content-based sites and online corporate and customer services.
LWW is part of Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health and pharmacy. Major brands include traditional publishers of medical and drug reference tools, journals, and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons®; and electronic information providers, such as Ovid®, UpToDate®, Medi-Span®, and ProVation® Medical.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Professionals in the areas of legal, business, tax, accounting, finance, audit, risk, compliance, and healthcare rely on Wolters Kluwer’s leading, information-enabled tools and solutions to manage their business efficiently, deliver results to their clients, and succeed in an ever more dynamic world. Wolters Kluwer has 2009 annual revenues of €3.4 billion ($4.8 billion), employs approximately 19,300 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices.